ArticleJAMA ophthalmology2026
A Clinically Relevant Threshold of Impaired Contrast Sensitivity Among Older US Adults.
Article in JAMA ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
Abstract
Importance: Contrast sensitivity (CS) is a critical yet underused measure of visual function that reflects the ability to detect subtle differences in luminance between an object and its background. Although poor CS is associated with falls, cognitive decline, and reduced independence in older adults, existing thresholds lack functional relevance. Objective: To identify a CS threshold associated with functional visual disability. Design, Setting, and Participants: This longitudinal cohort study used data from rounds 12 (2022) and 13 (2023) of the National Health and Aging Trends Study (NHATS), a nationally representative cohort study of Medicare beneficiaries aged 65 years and older in the US. Analyses included 4475 community-dwelling participants with available binocular contrast sensitivity and self-reported vision data. Data were analyzed from September 2024 to January 2026. Exposures: Logarithm-scaled, binocular-presenting CS (logCS). Main Outcomes and Measures: Self-reported visual disability (SRVD), defined by difficulty recognizing faces, reading newspaper print, or seeing the television across a room. Covariates include age, education, race, income, visual acuity, frailty, and multimorbidity. Multiple logistic regression models were used to examine the association between CS and SRVD, and survey-weighted receiver operating characteristic (ROC) curve analyses were performed to identify an optimal CS threshold using the Youden index. Results: Weighted mean logCS (SE) among participants was 1.72 (<0.01). At baseline, the mean contrast sensitivity in individuals with SRVD was 1.49 (0.03) logCS compared with 1.73 (<0.01) logCS among those without SRVD. Participants who developed new SRVD at 1-year follow-up demonstrated a mean decline in logCS from 1.62 to 1.56 logCS. Each 0.1-unit decrease in baseline logCS was independently associated with 12% higher odds of incident SRVD (odds ratio, 1.12; 95% CI, 1.08-1.16). A threshold of 1.60 logCS maximized discrimination for functional visual disability (sensitivity, 67% [95% CI, 62%-71%]; specificity, 70% [95% CI, 69%-72%]). Conclusions and Relevance: In this cohort study, a threshold of 1.60 logCS represented the functional threshold at which older adults began to experience SRVD. This functionally anchored cutoff provides a benchmark for interpreting CS measures, although sensitivity and specificity were moderate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.